GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 191 filers reported holding GENMAB A/S in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,084,447 | -67.8% | 30,747 | -65.3% | 0.01% | -63.6% |
Q2 2023 | $3,370,537 | +1357.1% | 88,675 | +1347.5% | 0.02% | +2100.0% |
Q1 2023 | $231,318 | -97.7% | 6,126 | -97.4% | 0.00% | -98.3% |
Q4 2022 | $9,906,367 | +106.9% | 233,751 | +56.9% | 0.06% | +114.8% |
Q3 2022 | $4,788,000 | +138.2% | 149,010 | +140.9% | 0.03% | +125.0% |
Q2 2022 | $2,010,000 | -29.9% | 61,857 | -21.9% | 0.01% | -50.0% |
Q1 2022 | $2,866,000 | +40.9% | 79,211 | +54.0% | 0.02% | +26.3% |
Q4 2021 | $2,034,000 | -25.7% | 51,427 | -17.9% | 0.02% | -44.1% |
Q3 2021 | $2,736,000 | -39.8% | 62,620 | -43.8% | 0.03% | -33.3% |
Q2 2021 | $4,547,000 | +479.2% | 111,359 | +365.9% | 0.05% | +410.0% |
Q1 2021 | $785,000 | +97.2% | 23,901 | +144.0% | 0.01% | +100.0% |
Q4 2020 | $398,000 | -62.1% | 9,797 | -65.8% | 0.01% | -68.8% |
Q3 2020 | $1,050,000 | -70.7% | 28,677 | -72.9% | 0.02% | -74.2% |
Q2 2020 | $3,584,000 | +848.1% | 105,756 | +493.3% | 0.06% | +520.0% |
Q1 2020 | $378,000 | -29.6% | 17,825 | -25.9% | 0.01% | 0.0% |
Q4 2019 | $537,000 | – | 24,058 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |